307 related articles for article (PubMed ID: 30309668)
1. Graft-versus-host disease.
Moreno DF; Cid J
Med Clin (Barc); 2019 Jan; 152(1):22-28. PubMed ID: 30309668
[TBL] [Abstract][Full Text] [Related]
2. Review of Cutaneous Graft-vs-Host Disease.
Ballester-Sánchez R; Navarro-Mira M; Sanz-Caballer J; Botella-Estrada R
Actas Dermosifiliogr; 2016 Apr; 107(3):183-93. PubMed ID: 26626500
[TBL] [Abstract][Full Text] [Related]
3. Life-threatening graft-vs-host disease.
Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal tract and liver graft-versus-host disease in pediatric patients with hematopoietic progenitor cell transplantation at a tertiary care center in Mexico.
Jaramillo-Esparza CM; Consuelo-Sánchez A; Acosta-Rodríguez-Bueno CP; Ramón-García G; Sadowinski-Pine SW; Escobar-Sánchez MA; Castorena-Villa I; Gaytán-Morales F; Vázquez-Frias R
Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):385-392. PubMed ID: 29486973
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
7. How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
Aizawa K; Peltier D; Matsuki E; Toubai T
Transfus Apher Sci; 2022 Apr; 61(2):103405. PubMed ID: 35210194
[TBL] [Abstract][Full Text] [Related]
8. Clinical update on graft-versus-host disease in children.
Goddard DS; Horn BN; McCalmont TH; Cordoro KM
Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host disease management.
Mistrik M; Bojtarova E; Sopko L; Masakova L; Roziakova L; Martinka J; Batorova A
Bratisl Lek Listy; 2016; 117(7):388-96. PubMed ID: 27546540
[TBL] [Abstract][Full Text] [Related]
10. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
Barton-Burke M; Dwinell DM; Kafkas L; Lavalley C; Sands H; Proctor C; Johnson E
Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):31-45. PubMed ID: 19856578
[TBL] [Abstract][Full Text] [Related]
12. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
Divito SJ; Aasebø AT; Matos TR; Hsieh PC; Collin M; Elco CP; O'Malley JT; Bækkevold ES; Reims H; Gedde-Dahl T; Hagerstrom M; Hilaire J; Lian JW; Milford EL; Pinkus GS; Ho VT; Soiffer RJ; Kim HT; Mihm MC; Ritz J; Guleria I; Cutler CS; Clark RA; Jahnsen FL; Kupper TS
J Clin Invest; 2020 Sep; 130(9):4624-4636. PubMed ID: 32516138
[TBL] [Abstract][Full Text] [Related]
13. Optimal management of chronic graft-versus-host disease in children.
Jacobsohn DA
Br J Haematol; 2010 Aug; 150(3):278-92. PubMed ID: 20553274
[TBL] [Abstract][Full Text] [Related]
14. The Role of Micronutrients in Graft-VS.-Host Disease: Immunomodulatory Effects of Vitamins A and D.
Chen X; Mayne CG
Front Immunol; 2018; 9():2853. PubMed ID: 30574143
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease: review and nursing implications.
Mattson MR
Clin J Oncol Nurs; 2007 Jun; 11(3):325-8. PubMed ID: 17623617
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic skin graft-versus-host disease--pathophysiological aspects.
Socié G; Peffault de Latour R; Bouziz JD; Rybojad M
Curr Probl Dermatol; 2012; 43():91-100. PubMed ID: 22377923
[TBL] [Abstract][Full Text] [Related]
17. Progress and prospects: graft-versus-host disease.
Mastaglio S; Stanghellini MT; Bordignon C; Bondanza A; Ciceri F; Bonini C
Gene Ther; 2010 Nov; 17(11):1309-17. PubMed ID: 20508597
[TBL] [Abstract][Full Text] [Related]
18. Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation.
Visentainer JE; Lieber SR; Persoli LB; de Souza Lima SC; Vigorito AC; Aranha FJ; Eid KA; Oliveira GB; Miranda EC; de Souza CA
Braz J Med Biol Res; 2002 May; 35(5):567-72. PubMed ID: 12011942
[TBL] [Abstract][Full Text] [Related]
19. Review of Graft-Versus-Host Disease.
Ramachandran V; Kolli SS; Strowd LC
Dermatol Clin; 2019 Oct; 37(4):569-582. PubMed ID: 31466596
[TBL] [Abstract][Full Text] [Related]
20. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]